Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
about
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy.Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma.PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
P2860
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
@ast
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
@en
type
label
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
@ast
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
@en
prefLabel
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
@ast
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
@en
P2093
P2860
P356
P1433
P1476
Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
@en
P2093
DingLi Liu
Hang Zheng
JinZhang Chen
RongCheng Luo
Yang Cheng
P2860
P304
23265-23276
P356
10.18632/ONCOTARGET.15575
P407
P577
2017-04-01T00:00:00Z